View in EDS

Combined Treatment for Patients with Brain Metastases from Non-small Cell Lung Cancer with Whole Brain Radiotherapy (WBRT) and Gefitinib (GFT) or Temozolomide (TMZ). A Randomized Multicenter Phase II Trial of the Swiss Group of Clinical Cancer Research (SAKK #70/03)

Saved in:
Bibliographic Details
Title: Combined Treatment for Patients with Brain Metastases from Non-small Cell Lung Cancer with Whole Brain Radiotherapy (WBRT) and Gefitinib (GFT) or Temozolomide (TMZ). A Randomized Multicenter Phase II Trial of the Swiss Group of Clinical Cancer Research (SAKK #70/03)
Authors: Pesce, G.A.1, Von Moos, R.2, D'Addario, G.3, Fischer, N.4, Caspar, C.B.5, Anchisi, S.6, Kotrubczik, N.7, Zouhair, A.8, Mayer, M.9, Stupp, R.8
Source: International Journal of Radiation Oncology, Biology, Physics. Nov2010 Supplement 1, Vol. 78 Issue 3, pS258-S258. 1p.
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2010.07.615